Logis Tablet 10/160 mg
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Saman Pharmaceutical Co., Ltd.
MFDS item code 201401987 · Approved 2014.04.24
This product's status changed to Expired on 2024.04.24. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of essential hypertension not controlled with monotherapy
This medicine is used to control blood pressure in patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with amlodipine or valsartan.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not adequately controlled with monotherapy using the individual components as follows, switching directly to this medicine may be considered. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
The safety and efficacy of this drug have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used by individuals who are allergic to this drug's active ingredients or similar class drugs, those who are pregnant or breastfeeding, and those with severe kidney or liver dysfunction. Particular caution is needed for diabetics or those with moderate to severe kidney impairment, as taking this drug with certain medications may pose risks. Before taking this medication, check for sodium or fluid depletion and supplement if necessary; if symptoms of hypotension occur, lie the patient down and take necessary actions. Patients with high potassium levels or kidney issues should frequently monitor their potassium levels while taking this drug and discontinue immediately if symptoms of angioedema appear. Patients with heart-related conditions, such as heart failure or post-myocardial infarction, and patients with aortic stenosis should use this drug with special caution. The risk of side effects like hypotension, worsening kidney function, and hyperkalemia may increase when this drug is taken with other antihypertensive medications, requiring close observation by healthcare professionals. Caution is advised during driving or operating machinery, as dizziness or fatigue may occur, particularly when first starting the medication due to potential sudden drops in blood pressure, necessitating careful monitoring. Elderly patients can be administered similar doses as adults, but dose adjustments may be necessary if there are issues with kidney or liver function. Severe symptoms such as hypotension, dizziness, and increased heart rate may occur in case of overdose, requiring immediate medical attention. This medication is not recommended for breastfeeding women, and its use in children is discouraged as safety and efficacy have not been sufficiently established.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and should be kept at a cool room temperature between 1 to 30 degrees Celsius.
Bright yellow rectangular film-coated tablet
28 tablets (14 tablets/PTP package x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Saman Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.